# Phase 4 hypertension trials recruiting: 67 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 67 trials in phase 4 for hypertension that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 hypertension trials: 67 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/hypertension

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 67
- Recruiting or not yet: 67
- Read on: November 19, 2026

## Trials

The 25 newest of 67, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 16, 2026 | NCT07938294 | Sotatercept in the Treatment of Methamphetamine-Associated Pulmonary Arterial Hypertension | Oregon Health and Science University | Phase 4 | Not yet recruiting | Pulmonary Arterial Hypertension (PAH), Methamphetamine Use Disorder | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938294) |
| November 12, 2026 | NCT07932145 | Early Mineralocorticoid Receptor Antagonist Therapy for Low-Renin Essential Hypertension | China National Center for Cardiovascular Diseases | Phase 4 | Not yet recruiting | Hypertension (HTN), Low-Renin Essential Hypertension | 128 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932145) |
| October 28, 2026 | NCT07899905 | A Clinical Study of MK-7962 in Chinese Participants With Pulmonary Arterial Hypertension (MK-7962-022) | Merck Sharp & Dohme LLC | Phase 4 | Not yet recruiting | Hypertension, Pulmonary | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07899905) |
| October 15, 2026 | NCT07876544 | Sitogilun Malate Plus Amlodipine in Patients With Hypertension and Risk of Early Kidney Damage | Shanghai Jiao Tong University School of Medicine | Phase 4 | Recruiting | Hypertension | 456 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07876544) |
| September 30, 2026 | NCT07848828 | Autonomic and Renal Contributions to Hypertension With ADT | Virginia Commonwealth University | Phase 4 | Recruiting | Androgen Deprivation Therapy, Prostate Cancer, Hypertension, Autonomic Dysfunction, Renal Disease | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07848828) |
| August 12, 2026 | NCT07759804 | A Study of Inhaled Treprostinil (LIQ861) in Adults With Pulmonary Arterial Hypertension Transitioning From Oral Selexipag | Liquidia Technologies, Inc. | Phase 4 | Recruiting | Pulmonary Arterial Hypertension (PAH) | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07759804) |
| July 20, 2026 | NCT07713914 | Randomized Study of Triple Therapy vs Sildenafil Dose Optimization in Pulmonary Arterial Hypertension | University of Sao Paulo General Hospital | Phase 4 | Recruiting | Pulmonary Arterial Hypertension (PAH) | 196 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07713914) |
| July 15, 2026 | NCT07704190 | Effect of Secukinumab on Cardiorenal Outcomes in Patients With Cardiorenal Metabolic Syndrome and Atherosclerotic Cardiovascular Disease | Peking University Third Hospital | Phase 4 | Not yet recruiting | Cardiorenal Metabolic Syndrome, Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease, Coronary Artery... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07704190) |
| July 7, 2026 | NCT07687160 | SPIRO-First: A Pragmatic Primary Care-Embedded Pilot Trial of Renin-Guided First-Line Antihypertensive Therapy | Ottawa Hospital Research Institute | Phase 4 | Not yet recruiting | Hypertension | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07687160) |
| May 26, 2026 | NCT07607275 | Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension | Beijing Anzhen Hospital | Phase 4 | Recruiting | Hypertension, Essential (Primary) Hypertension | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07607275) |
| May 22, 2026 | NCT07600723 | A Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) in India (MK-7962-037) | Merck Sharp & Dohme LLC | Phase 4 | Recruiting | Pulmonary Arterial Hypertension | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07600723) |
| May 14, 2026 | NCT07588152 | Imaging the Effects of Netarsudil (Rhopressa) on the Trabecular Meshwork in Glaucoma and Ocular Hypertension | Indiana University | Phase 4 | Recruiting | Glaucoma, Ocular Hypertension | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07588152) |
| April 9, 2026 | NCT07521332 | Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis | Asian Institute Of Medical Sciences | Phase 4 | Recruiting | Cirrhosis, Esophageal and Gastric Varices, Ascites, Hepatic Encephalopathy, Portal Vein Thrombosis, Portal Hypertension | 220 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07521332) |
| March 19, 2026 | NCT07483801 | DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies | Cambridge University Hospitals NHS Foundation Trust | Phase 4 | Not yet recruiting | Cardiovascular Diseases | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07483801) |
| January 28, 2026 | NCT07373756 | Randomized Controlled Study to Compare Efficacy of Aspirin 75mg and 150mg In the Prevention of Preeclampsia In High Risk Pregnant Women | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Pregnancy Induced Hypertension (PIH) | 86 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07373756) |
| January 22, 2026 | NCT07359599 | The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension | Ziekenhuis Oost-Limburg | Phase 4 | Recruiting | Pulmonary Hypertension, Iron Deficiency | 306 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07359599) |
| January 21, 2026 | NCT07356778 | A Study of Sotatercept for Patients With Eisenmenger Syndrome or Unrepaired Shunt-Associated Pulmonary Arterial Hypertension Resistant to... | Sponsor not shown (see the record) | Phase 4 | Recruiting | Eisenmenger Syndrome, Pulmonary Arterial Hypertension of Congenital Heart Disease | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07356778) |
| January 8, 2026 | NCT07325240 | 24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients | Mayo Clinic | Phase 4 | Recruiting | Open Angle Glaucoma, Ocular Hypertension | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07325240) |
| January 7, 2026 | NCT07322133 | Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE) | University of California, Davis | Phase 4 | Recruiting | Hypotension and Shock, Pulmonary Hypertension of the Newborn (PPHN), Hypoxemic Respiratory Failure | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07322133) |
| December 19, 2025 | NCT07293728 | A Randomized Feasibility Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia | Oregon Health and Science University | Phase 4 | Not yet recruiting | Hypertension, Preeclampsia | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07293728) |
| December 9, 2025 | NCT07271420 | Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients | Chinese University of Hong Kong | Phase 4 | Recruiting | Hypertension, Peritoneal Dialysis, End Stage Kidney Disease (ESRD) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07271420) |
| November 25, 2025 | NCT07247240 | Efficacy of Inhaled Nitric Oxide in Congenital Diaphragmatic Hernia | Asan Medical Center | Phase 4 | Not yet recruiting | Congenital Diaphragmatic Hernia, Pulmonary Hypertension | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07247240) |
| November 25, 2025 | NCT07247162 | Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome | RECORDATI GROUP | Phase 4 | Recruiting | Hypertension, Hypercortisolemia, Cushing Syndrome | 63 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07247162) |
| November 25, 2025 | NCT07247058 | Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS) | Johns Hopkins University | Phase 4 | Recruiting | Mild Autonomous Cortisol Secretion (MACS) | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07247058) |
| November 21, 2025 | NCT07241338 | Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Hypertension | 104 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07241338) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Chinese University of Hong Kong | 2 |
| Nebraska Methodist Health System | 2 |
| Oregon Health and Science University | 2 |
| Ohio State University | 2 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 2 |
| China National Center for Cardiovascular Diseases | 2 |
| Brigham and Women's Hospital | 2 |
| National Taiwan University Hospital | 2 |
| Shenzhen Ausa Pharmed Co.,Ltd | 2 |
| Taipei Veterans General Hospital, Taiwan | 2 |
| University of California, Davis | 1 |
| Fundación EPIC | 1 |
| University Medical Center Groningen | 1 |
| Ottawa Hospital Research Institute | 1 |
| University of Missouri-Columbia | 1 |
| Johns Hopkins University | 1 |
| University of Alberta | 1 |
| [RECORDATI GROUP](https://specstream.ai/data/clinical-trials/company/recordati-group) | 1 |
| [Glaukos Corporation](https://specstream.ai/data/clinical-trials/company/glaukos-corporation) | 1 |
| University of Sao Paulo General Hospital | 1 |
| Asan Medical Center | 1 |
| Liquidia Technologies, Inc. | 1 |
| Indiana University | 1 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Peking University Third Hospital | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 25 |
| China | 12 |
| Taiwan | 4 |
| Netherlands | 3 |
| Spain | 2 |
| Hong Kong | 2 |
| Canada | 2 |
| Brazil | 2 |
| Belgium | 2 |
| Japan | 2 |
| South Korea | 1 |
| Argentina | 1 |
| Austria | 1 |
| Czechia | 1 |
| France | 1 |
| Germany | 1 |
| Hungary | 1 |
| Italy | 1 |
| Poland | 1 |
| Portugal | 1 |
| Romania | 1 |
| Uruguay | 1 |
| United Kingdom | 1 |
| Denmark | 1 |
| Pakistan | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Powder coating companies in the United States](https://specstream.ai/data/businesses/powder-coating-companies/united-states)
- [Jewelry and watches manufacturers in the United States](https://specstream.ai/data/businesses/jewelry-and-watches-manufacturers/united-states)
- [Energy management companies in the United States](https://specstream.ai/data/businesses/energy-management-companies/united-states)
- [Blueprint printers in the United States](https://specstream.ai/data/businesses/blueprint-printers/united-states)
- [Uzbek restaurants in the United States](https://specstream.ai/data/businesses/uzbek-restaurants/united-states)
- [Private jet charter companies in the United States](https://specstream.ai/data/businesses/private-jet-charter-companies/united-states)
